Boston Scientific Corporation
BSX
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardiovā¦ read more
Healthcare
Medical Devices
33 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$100.02
Price+0.98%
$0.97
1Y
Price
Market Cap
$148.274b
Large
Price/Earnings 3y Avg5y Avg
53.5x
Premium
Premium
Financials Overview
Key metrics over the past few years+20.2%
EBITDA Margin+14.9%
Net Profit Margin+21.6%
Free Cash Flow MarginRevenue
$19.350b
+15.5%
1y CAGR+15.2%
3y CAGR+13.0%
5y CAGREarnings
$2.788b
+50.4%
1y CAGR+65.0%
3y CAGR+40.5%
5y CAGREPS
$1.86
+48.8%
1y CAGR+67.8%
3y CAGR+42.2%
5y CAGRBook Value
$22.653b
$41.559b
Assets$18.906b
Liabilities$12.027b
DebtDebt to Assets
28.9%
2.6x
Debt to EBITDAFree Cash Flow
$3.311b
+25.2%
1y CAGR+55.6%
3y CAGR+34.1%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company